TB Outcome of DOTS Category I TB Cases Started on Re-treatment with Category II Regimen during the Years 2002 to 2015, in a Slum in Delhi
Abstract
Objective: This study of TB Cat I cases retreated with Cat II treatment at a DOTS centre, was under taken to gather evidence as to whether TB patients are mostly relapse cases or failure cases and if there is any difference in their final outcome after retreatment.
Methods: The secondary data maintained for a total of 1941 TB patients in the TB register, who were registered & treated from 2002 to the year 2015 at Community Health Department (CHD) DOTS centre of a tertiary care hospital of Delhi was accessed and was entered in excel sheet and Statistical analysis was done using and MedCalc Software bvba [BE]. Out of 1301 total Cat I cases 94 were found who were restarted on Cat II regimen. Out of these 58 (61.7%) were Relapse cases and 36 (38.29%) failure cases.
Result: The mean age was 32.03 with SD+16.33 years and 53.19% were males among 94 Cat I cases enrolled for retreatment. The Cat I Failure cases put on Cat II, showed failure in 12 (33.33%) Vs. failure in relapse cases 10 (17.24%). This low success to treatment (cured and Treatment completed) rate in Failure cases was highly significant (p<0.0001).
Conclusion: TB treatment outcome matters a lot. If a TB patient is not cured or does not complete treatment her/his TB could become Drug Resistant. All TB patients should be prevented from becoming failure cases during the course of treatment. If this is done TB morbidity and mortality could be controlled.
How to cite this article:
Vaghela JF, Mangal A. TB Outcome of DOTS Category I TB Cases Started on Re-treatment with Category II Regimen during the Years 2002 to 2015, in a Slum in Delhi. J Commun Dis 2019; 51(4): 62-68.
DOI: https://doi.org/10.24321/0019.5138.201938
References
World Health Organization. Global tuberculosis report 2018. Accessed on 19.7.2019, Available from: https://
www.who.int/tb/publications/global_report/en/;https://www.scribd.com/document/396888065/
Global-Tuberculosis-Report-2018-pd.
World Health Organization. Global Tuberculosis Report. 20th Edition. Accessed on 16 June 2019. Available from:
http://www.who.int/tb/publications/global_report/high_tb_burdencountrylists2016-020.pdf?ua=1.
Revised National Tuberculosis Control Programme (RNTCP). Accessed on 18 July2019. Available from:
https://www.nhp.gov.in/revised-national-tuberculosiscontrol-programme_pg; https://www.manifestias.
com/2019/09/12/revised-national-tuberculosiscontrol-programme/.
Kanabus A. “Information about Tuberculosisâ€, GHE. Accessed on 16 June 2019. Available from: https://
www.tbfacts.org/tb-statistics/.
Behera D, Balamugesh T. ‘Profile of treatment failure in tuberculosis–Experience from a tertiary care hospital’.
Lung India 2006; 23(1): 103-105. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29531444 [PubMed].
World Health Organization. Treatment of tuberculosis. Guidelines for National Programmes. WHO/CDS/
TB/2003.313. Geneva, Switzerland: WHO, 2003.
Accessed on 16 July 2019. Available from: https://apps.who.int/iris/bitstream/handle/10665/67890/
WHO_CDS_TB_2003.313_eng.pdf;sequence=1.
Central TB Division. Technical and Operational Guidelines for Tuberculosis Control Central TB Division
Directorate General of Health Services Ministry of Health and Family Welfare, Nirman Bhavan, New
Delhi 110011. 2005, pp 22-23. Accessed on 26 July 2019. Available from: http://health.bih.nic.in/Docs/
Guidelines/Guidelines-TB-Control.pdf.
Medcalc’s odds ratio calculator. Accessed on 30 July 2019. Available from: https://www.medcalc.org/calc/
odds_ratio.php.
Chandrasekaran V, Gopi PG, Santha T, Subramani R, Narayanan PR. Status of re-registered patients for
tuberculosis treatment under DOTS programme. Indian J Tuberc. 2007; 54(1): 12-16. Available from: www.ncbi.
nlm.nih.gov › pubmed › 17455418 [Pubmed].
Dolma KG, Adhikari L, Dadul P, Laden T, Singhi L, Mahanta J. A study on the assessment of retreatment
of Tuberculosis patients attending the DOTS centre in Sikkim, India from 2002 to 2010. Research Journal of
Infectious Diseases 2013, 1: 3. Available from: http://www.hoajonline.com/infectdis/2052-5958/1/3#.
Mehra RK, Dhingra VK, Agarwal N, Vashist RP. Study of relapse and failure cases of CAT I retreated with CAT
II under RNTCP - An eleven-year follow-up. Indian J Tuberc 2008; 55(4): 188-191. Available from: www.
ncbi.nlm.nih.gov › pubmed [Pubmed].
Varshney AM, Singh US, Kumar D. Sources of Antitubercular drugs exposure for patient registered in
RNTCP as Retreatment cases in District Anand, Gujarat. Indian Journal of Community Health 2013; 25(2): 159-63. Available from: www.iapsmupuk.org › journal › index.php › IJCH › article › view [Google Scholar].
Dhingra VK, Rajpal S, Aggarwal N, et al. Treatment outcome of Category II regimens in ‘Failure’ & ‘Relapse’
subgroups and their follow up. Indian J Tuberc 2006; 53: 55. Available from: www.researchgate.net › figure
› Treatment-outcome-of-failure-and-rela. [Research Gate].
Chadha SL, Bhagi RP. Treatment outcome of tuberculosis patients placed under directly observed treatment
short course (DOTS) - a cohort study. Indian J Tuberc 2000; 47: 155. Available at: www.ncbi.nlm.nih.gov ›
pmc › articles › PMC2822324 [PubMed].
Central Tuberculosis Division. Tuberculosis India. Annual Report of the Revised National Tuberculosis Control
Programme. Directorate General of Health Services, Ministry of Health and Family Welfare, Government
of India. 2010. Available from: http://health.bih.nic.in/Docs/Guidelines/Guidelines-DOTS-Plus.pdf.
Kritski AL, Rodrigues de Jesus LS, Andrade MK et al. Retreatment tuberculosis cases: Factors associated
with drug resistance and adverse outcomes. Chest 1997; 111(5): 1162-1167. Available from: www.ncbi.
nlm.nih.gov › pubmed PMID: 9149564. [PubMed/ Google Scholar].
Chavez Pachas AM, Blank R, Smith F, Bayona J, Becerra MC, Mitnick CD et al. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru. Int J Tubrc Lung Dis. 2004; 8(1): 52-58. Available from: www.researchgate.net › publication
› 7185891_Identifying_early_treat.. [Research Gate]; www.ncbi.nlm.nih.gov › pubmed PMID:14974746
[PubMed].
Santha T, Gopi PG, Rajeswari R, Nagamiah S. Is it worth treating Category I failure patients with Category II
regimen? Indian J Tuberc 2005; 52(4): 203. Available from: www.researchgate.net › publication › 265422271_
Is_it_worth_treating_... [Research Gate]; medind.nic. in › ibr.
Kimerling ME, Kluge H, Vezhnina N, Iacovazzi T, Demeulenaere T, Portaels F et al. Inadequacy of
the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB. Int J
Tuberc Lung Dis. 1999; 3(5): 451-453. Available from: https://www.ncbi.nlm.nih.gov/pubmed/10331736/
[PubMed]; www.researchgate.net › publication › 12966464_Inadequacy_of_the_cu... [Research Gate].
Copyright (c) 2020 Journal of Communicable Diseases (E-ISSN: 2581-351X & P-ISSN: 0019-5138)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
